Investigational Drug Information for Tideglusib
✉ Email this page to a colleague
What is the development status for investigational drug Tideglusib?
Tideglusib is an investigational drug.
There have been 8 clinical trials for Tideglusib.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 23rd 2021.
The most common disease conditions in clinical trials are Myotonic Dystrophy, Alzheimer Disease, and Paralysis. The leading clinical trial sponsors are AMO Pharma Limited, Noscira SA, and Evdokia Anagnostou.
There are seventeen US patents protecting this investigational drug and one hundred and ten international patents.
Summary for Tideglusib
US Patents | 17 |
International Patents | 110 |
US Patent Applications | 125 |
WIPO Patent Applications | 115 |
Japanese Patent Applications | 16 |
Clinical Trial Progress | Phase 2 (2021-08-23) |
Vendors | 76 |
Recent Clinical Trials for Tideglusib
Title | Sponsor | Phase |
---|---|---|
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis | Cantonal Hospital of St. Gallen | Phase 2 |
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis | University of Bern | Phase 2 |
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis | University of Lausanne Hospitals | Phase 2 |
Clinical Trial Summary for Tideglusib
Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib
US Patents for Tideglusib
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Tideglusib | ⤷ Try a Trial | Compositions and methods for treating cancers | CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) | ⤷ Try a Trial |
Tideglusib | ⤷ Try a Trial | Reprogramming fibroblasts into cardiomyocytes | THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (San Francisco, CA) | ⤷ Try a Trial |
Tideglusib | ⤷ Try a Trial | Thermoreversible compositions for administration of therapeutic agents | Frequency Therapeutics, Inc. (Woburn, MA) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tideglusib
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Tideglusib | Australia | AU2015274334 | 2034-06-12 | ⤷ Try a Trial |
Tideglusib | Australia | AU2021201667 | 2034-06-12 | ⤷ Try a Trial |
Tideglusib | Australia | AU2023200895 | 2034-06-12 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |